Market Brief

The articles are produced in Chinese only.


倪國權先生 (Alex Ni)


Modern Dental Group Limited (3600)

Wednesday, September 18, 2019 Views2357


Stock Commentary                                                    Date: 17/9/2019


Stock:                                                     Modern Dental Group Limited

Closing price:                                      $1.45 (17/09/2019)

52 weeks range:                                         $0.94 - $1.717

Shares outstanding:                               981,646,000

Market Capitalization:                         HK$ 1.423 Billion

Target Price (12 months):                        No Target


Summary :

  1. The group is in the transition phase period, consolidating their business through various acquisitions.
  1. Focus on higher value products to improve profit margins.
  1. The incurred loss was from restructuring, re-financing and currency exchange. The group’s core business remained relatively stable.
  1. The group’s prospect came from local market penetration through their strategic geographical acquisitions.
  1. Greater China may be the company’s next sales engine as GDP per capita increased, so was the demand for high quality medical/dental care products.
  1. The group continued to showed prudent use of capital amid the current uncertain economic period.
  1. The group continued to repurchase stocks from market to support the stock value.


Group half yearly report (June 2019):

  1. Improvement in gross profit (and gross profit margin). However, the transition phase is still in progress and remained to be seen.

2 While Europe continued to be one of the major contributors of the group’s revenue, Greater China region had a faster growth comparing to other region while North America (including Canada) also had a moderate improvement in terms of revenue growth. As the group continued to consolidate with their acquisitions (especially with MicroDental), the company expected to capitalize on their investments in the future.

3.  The group continued to show improvement with their operation, highlighted by their improvement in EBITDA.

4. The group’s cash level as well as liquidity remained to be solid and showed prudency with their financing strategy as well as capital planning

「註:本人倪國權為證監會持牌人士。截至本評論文章發表日止,本人及/或其有聯繫者並無持有全部提及之証券的所有相關財務權益。」; Or
” I, Ni Kwok Kuen Alex, am a licensed person under the Securities and Futures Commission. Until the date this commentary was published, neither I and/or my affiliates are the beneficiary of the securities mentioned herein or are entitled to any financial interests in relation thereto. “

This report is produced and is being distributed in Hong Kong by Phillip Securities Group with the Securities and Futures Commission (“SFC”) licence under Phillip Securities (HK) LTD and/ or Phillip Commodities (HK) LTD (“Phillip”). Information contained herein is based on sources that Phillip believed to be accurate. Phillip does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The information is for informative purposes only and is not intended to or create/induce the creation of any binding legal relations. The information provided do not constitute investment advice, solicitation, purchase or sell any investment product(s). Investments are subject to investment risks including possible loss of the principal amount invested. You should refer to your Financial Advisor for investment advice based on your investment experience, financial situation, any of your particular needs and risk preference. For details of different product's risks, please visit the Risk Disclosures Statement on Phillip (or employees) may have positions/ interests in relevant investment products. Phillip (or one of its affiliates) may from time to time provide services for, or solicit services or other business from, any company mentioned in this report. The above information is owned by Phillip and protected by copyright and intellectual property Laws. It may not be reproduced, distributed or published for any purpose without prior written consent from Phillip.
Top of Page
Contact Us
Please contact your account executive or call us now.
Research Department
Tel : (852) 2277 6846
Fax : (852) 2277 6565
Email :

Enquiry & Support
The Complaint Procedures
Louis Talk
Investor Notes
Free Subscribe
Contact Us